Mechanism For Meth Addiction Discovered

Main Category: Alcohol / Addiction / Illegal Drugs
Also Included In: Neurology / Neuroscience;  Biology / Biochemistry
Article Date: 10 Apr 2008 - 4:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Researchers have identified, for the first time, long-term changes in the brain circuitry of methamphetamine-addicted mice that can explain why the craving of addiction is so stubborn and long-lived. The research could lead to more effective treatments for addiction to methamphetamine and related drugs.

Nigel Bamford and colleagues published their findings in the April 10, 2008, issue of the journal Neuron, published by Cell Press.

In their experiments, the researchers treated mice with methamphetamine and studied how long exposure to the drug affected levels of the brain chemical dopamine. Researchers have long known that methamphetamine and amphetamine enhance release of dopamine at the connections between neurons, called synapses. Dopamine is one of the brain's major neurotransmitters, the chemical messengers by which one neuron triggers its neighbor to fire a nerve impulse.

The researchers concentrated on the dopamine machinery in the brain's corticostriatal region, believed to harbor the "habit" circuitry central to the compulsive drug-seeking of addiction to methamphetamine and amphetamine.

To reveal the flow of dopamine, they used a fluorescent tracer dye that is taken up by the same microscopic sacs, called vesicles, that store and release dopamine in the process of signaling between neurons. Using microscopy to follow the movement of the dye, they could study how methamphetamine affected the dopamine transport machinery in the brain.

Their studies revealed that giving the animals the drug long enough to cause chronic effects caused a depression of the synaptic dopamine machinery in the corticostriatal region that lasted for months after the drug was withdrawn. However, giving the animals a dose of methamphetamine reversed the depressive effects on the synaptic machinery.

The researchers' experiments also revealed details of how the drug produced its long-term effect - by altering specific types of receptors for dopamine and another neurotransmitter, acetylcholine.

They concluded that the mechanism they discovered "might provide a synaptic basis that underlies addiction and habit learning and their long-term maintenance."

In a preview of the article in the same issue of Neuron, Jeremy Day and Regina Carelli speculated that the drug effects that the researchers discovered might disrupt the normal machinery for learning in the brain, "leading to aberrant reward processing and action selection. If so, the discovery of methods to reverse this plasticity may be a promising avenue for addiction treatment," they wrote.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

The researchers include Nigel S. Bamford, University of Washington, Seattle, WA, University of Washington and Children's Hospital and Regional Medical Center, Seattle, WA; Hui Zhang, Columbia University College of Physicians and Surgeons, New York, NY; John A. Joyce, University of Washington, Seattle, WA; Christine A. Scarlis, University of Washington, Seattle, WA; Whitney Hanan, University of Washington, Seattle, WA; Nan-Ping Wu, Mental Retardation Research Center, The David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA; Veronique M. Andre, Mental Retardation Research Center, The David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA; Rachel Cohen, Mental Retardation Research Center, The David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA; Carlos Cepeda, Mental Retardation Research Center, The David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA; Michael S. Levine, Mental Retardation Research Center, The David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA; Erin Harleton, Columbia University College of Physicians and Surgeons, New York, NY; and David Sulzer, Columbia University College of Physicians and Surgeons, New York, NY, Columbia University College of Physicians and Surgeons, New York, NY, New York State Psychiatric Institute, New York, NY.

Source: Cathleen Genova
Cell Press